Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Germany
Clinical trial register · Germany

Clinical Trials in Germany

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
Berlin 3 Ulm 3 Essen 2 Hanover 2 Leipzig 2

Trials in this register

7 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Heidelberg, Mannheim, Regensburg
2025-01-22
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
55
Berlin, Düsseldorf, Frankfurt, Hanover, Ulm
2024-12-16
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Dresden, Düsseldorf, Göttingen, Leipzig, Munich
2024-12-03
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Essen, Hamburg, Heidelberg, Mannheim
2020-01-05
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Berlin, Lübeck, München
2019-03-21
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
Institut de Recherches Internationales Servier
Phase 3
146
Essen, Chemnitz, Berlin, Hanover, Leipzig, München, Ulm
2017-06-26
Active, closed
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
NCT02632708Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), AML Arising From Antecedent Hematologic Disorder (AHD)
Institut de Recherches Internationales Servier
Phase 1
153
Ulm
2015-12-31
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-germany

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Germany?

1 of the 7 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 7 studies
PhaseStudiesRecruitingShare
Phase 34157.1%
Phase 1/22028.6%
Phase 11014.3%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Institut de Recherches Internationales Servier71

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Newly Diagnosed Acute Myeloid Leukemia (AML) (2) Untreated AML (2) AML Arising From Myelodysplastic Syndrome (MDS) (2) Leukemia, Myeloid, Acute (1) Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) (1) Myelodysplastic Syndromes (MDS) (1) Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation (1) IDH1-mutant Glioma (1) IDH2-mutant Glioma (1) AML Arising From Antecedent Hematologic Disorder (AHD) (1) Grade 2 Glioma (1) Residual Glioma (1) Recurrent Glioma (1) Metastatic Colorectal Cancer (1)
→

Browse trials by site location

Berlin (3) Ulm (3) Essen (2) Hanover (2) Leipzig (2) München (2) Düsseldorf (2) Heidelberg (2) Mannheim (2) Chemnitz (1) Dresden (1) Göttingen (1) Munich (1) Frankfurt (1) Regensburg (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.